LORI KAY: Open Payments
NPI 1447703251 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,708 in 125 payments from 13 companies in 2025. Trend: 2023 $1,739 · 2024 $2,242 · 2025 $2,708
Food & beverage: $2,596Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 18 | $521 |
| Vanda Pharmaceuticals Inc. | 12 | $349 |
| E.R. Squibb & Sons, L.L.C. | 13 | $313 |
| ABBVIE INC. | 17 | $280 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $273 |
| Neurocrine BioSciences, Inc. | 16 | $265 |
| Axsome Therapeutics, Inc. | 13 | $182 |
| Alkermes, Inc. | 6 | $168 |
| Otsuka America Pharmaceutical, Inc. | 5 | $162 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $114 |
Products named: FANAPT, COBENFY, VRAYLAR, CAPLYTA, INGREZZA, UZEDY, AUSTEDO XR, Auvelity.
Industry payments across LA — which companies pay providers there.
